ONTOLOGY REPORT - ANNOTATIONS
| Term: | 4-vinylcyclohexene dioxide |
|
| Accession: | CHEBI:59001
|
browse the term
|
| Definition: | The diepoxide of 4-vinylcyclohexene. |
| Synonyms: | exact_synonym: | 3-(oxiran-2-yl)-7-oxabicyclo[4.1.0]heptane |
| | related_synonym: | 1-Epoxyethyl-3,4-epoxycyclohexane; 1-Ethyleneoxy-3,4-epoxycyclohexane; 1-Vinyl-3-cyclohexene dioxide; 3-(1,2-Epoxyethyl)-7-oxabicyclo(4.1.0)heptane; 3-(Epoxyethyl)-7-oxabicyclo(4.1.0)heptane; 3-Oxiranyl-7-oxabicyclo(4.1.0)heptane; 4-(1,2-Epoxyethyl)-7-oxabicyclo(4.1.0)heptane; 4-(Epoxyethyl)-7-oxabicyclo(4.1.0)heptane; 4-Vinyl-1,2-cyclohexene diepoxide; 4-Vinyl-1-cyclohexene dioxide; 4-Vinylcyclohexene diepoxide; C1CC2OC2CC1C1CO1; C8H12O2; InChI=1S/C8H12O2/c1-2-6-7(10-6)3-5(1)8-4-9-8/h5-8H,1-4H2; InChIKey=OECTYKWYRCHAKR-UHFFFAOYSA-N; Vinyl cyclohexene diepoxide; Vinyl cyclohexene dioxide |
| | xref_casrn: | 106-87-6 |
| | xref: | Beilstein:106071 "Beilstein Registry Number"; ChEMBL:1215038 "ChEMBL COMPOUND"; ChemIDplus:106-87-6 "CAS Registry Number"; CiteXplore:3356477 "PubMed citation" |
| | xref_mesh: | MESH:C012606 |
|
|
4-vinylcyclohexene dioxide
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
affects expression |
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
affects expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adam10 |
ADAM metallopeptidase domain 10 |
|
affects expression |
ISO |
8 |
75,200,657 |
75,289,572 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
increases expression |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
increases expression |
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
decreases expression |
EXP |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Ap1s1 |
adaptor-related protein complex 1, sigma 1 subunit |
|
affects expression |
ISO |
12 |
20,907,855 |
20,918,301 |
RGD:6480464 |
CTD |
| G |
Araf |
v-raf murine sarcoma 3611 viral oncogene homolog |
|
affects expression |
ISO |
X |
12,556,904 |
12,568,583 |
RGD:6480464 |
CTD |
| G |
Arf2 |
ADP-ribosylation factor 2 |
|
affects expression |
ISO |
10 |
93,114,540 |
93,136,313 |
RGD:6480464 |
CTD |
| G |
Arf3 |
ADP-ribosylation factor 3 |
|
affects expression |
ISO |
7 |
137,505,200 |
137,510,262 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
affects expression |
ISO |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
affects expression |
ISO |
6 |
72,685,231 |
72,693,052 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
affects expression |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Atrx |
alpha thalassemia/mental retardation syndrome X-linked |
|
affects expression |
ISO |
X |
93,903,794 |
94,051,337 |
RGD:6480464 |
CTD |
| G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
|
affects expression |
ISO |
12 |
22,586,411 |
22,644,378 |
RGD:6480464 |
CTD |
| G |
Bcam |
basal cell adhesion molecule (Lutheran blood group) |
|
affects expression |
ISO |
1 |
79,067,352 |
79,081,739 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
affects expression |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bclaf1 |
BCL2-associated transcription factor 1 |
|
affects expression |
ISO |
1 |
15,605,220 |
15,632,005 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
affects expression |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
affects expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
affects expression |
ISO |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Casp2 |
caspase 2 |
|
increases expression |
ISO |
4 |
70,029,728 |
70,047,164 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
affects expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
affects expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
affects expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
affects expression |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
affects expression |
ISO |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
affects expression |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Csn2 |
casein beta |
|
decreases expression |
EXP |
14 |
21,847,981 |
21,855,216 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
affects expression |
ISO |
3 |
142,564,754 |
142,609,311 |
RGD:6480464 |
CTD |
| G |
Ctcfl |
CCCTC-binding factor (zinc finger protein)-like |
|
affects expression |
ISO |
3 |
163,952,971 |
163,973,834 |
RGD:6480464 |
CTD |
| G |
Cxxc1 |
CXXC finger protein 1 |
|
affects expression |
ISO |
18 |
71,006,887 |
71,011,947 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects response to substance |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
affects expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dhx9 |
DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
|
affects expression |
ISO |
13 |
68,471,256 |
68,507,999 |
RGD:6480464 |
CTD |
| G |
Diaph1 |
diaphanous homolog 1 (Drosophila) |
|
affects expression |
ISO |
18 |
30,757,191 |
30,855,548 |
RGD:6480464 |
CTD |
| G |
Dlg4 |
discs, large homolog 4 (Drosophila) |
|
increases expression |
ISO |
10 |
56,864,459 |
56,890,626 |
RGD:6480464 |
CTD |
| G |
Dnm1l |
dynamin 1-like |
|
affects expression |
ISO |
11 |
86,617,236 |
86,665,861 |
RGD:6480464 |
CTD |
| G |
Dock1 |
dedicator of cyto-kinesis 1 |
|
affects expression |
ISO |
1 |
194,172,914 |
194,795,629 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
affects expression |
ISO |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
affects expression |
ISO |
20 |
4,021,679 |
4,033,709 |
RGD:6480464 |
CTD |
| G |
Eif2ak4 |
eukaryotic translation initiation factor 2 alpha kinase 4 |
|
affects expression |
ISO |
3 |
104,870,871 |
104,875,529 |
RGD:6480464 |
CTD |
| G |
Eif2s3 |
eukaryotic translation initiation factor 2, subunit 3 gamma |
|
affects expression |
ISO |
X |
81,542,853 |
81,566,259 |
RGD:6480464 |
CTD |
| G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
|
affects expression |
ISO |
1 |
267,369,497 |
267,399,705 |
RGD:6480464 |
CTD |
| G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
|
affects expression |
ISO |
1 |
185,691,630 |
185,709,514 |
RGD:6480464 |
CTD |
| G |
Eif4g1 |
eukaryotic translation initiation factor 4 gamma, 1 |
|
affects expression |
ISO |
11 |
82,451,555 |
82,471,735 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
affects expression |
ISO |
12 |
1,459,046 |
1,500,042 |
RGD:6480464 |
CTD |
| G |
Elavl2 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
|
affects expression |
ISO |
5 |
111,178,875 |
111,304,980 |
RGD:6480464 |
CTD |
| G |
Elf2 |
E74-like factor 2 |
|
affects expression |
ISO |
2 |
140,144,023 |
140,221,693 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
multiple interactions |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases metabolic processing |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases metabolic processing |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Etv5 |
ets variant 5 |
|
affects expression |
ISO |
11 |
80,846,286 |
80,904,013 |
RGD:6480464 |
CTD |
| G |
Fmr1 |
fragile X mental retardation 1 |
|
affects expression |
ISO |
X |
154,756,031 |
154,793,782 |
RGD:6480464 |
CTD |
| G |
Foxn3 |
forkhead box N3 |
|
affects expression |
ISO |
6 |
123,385,156 |
123,762,322 |
RGD:6480464 |
CTD |
| G |
Foxp1 |
forkhead box P1 |
|
affects expression |
ISO |
4 |
133,773,373 |
134,007,018 |
RGD:6480464 |
CTD |
| G |
Fus |
fused in sarcoma |
|
affects expression |
ISO |
1 |
187,250,871 |
187,264,742 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
affects expression |
ISO |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
affects expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gna13 |
guanine nucleotide binding protein (G protein), alpha 13 |
|
affects expression |
ISO |
10 |
98,933,205 |
98,965,819 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
affects expression |
ISO |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Gpbp1 |
GC-rich promoter binding protein 1 |
|
affects expression |
ISO |
2 |
42,751,497 |
42,800,922 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
affects expression |
ISO |
14 |
92,814,797 |
92,911,442 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
affects expression |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
H3f3c |
H3 histone, family 3C |
|
affects expression |
ISO |
7 |
91,621,341 |
91,621,751 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
affects expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hipk2 |
homeodomain interacting protein kinase 2 |
|
affects expression |
ISO |
4 |
66,273,623 |
66,455,774 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
affects expression |
ISO |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
affects expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
affects expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
affects expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
affects expression |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
affects expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itgav |
integrin, alpha V |
|
affects expression |
ISO |
3 |
66,953,403 |
67,029,774 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
affects expression |
ISO |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnab1 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
|
affects expression |
ISO |
2 |
154,837,841 |
155,145,882 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
affects expression |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Kif5b |
kinesin family member 5B |
|
affects expression |
ISO |
17 |
59,697,082 |
59,727,314 |
RGD:6480464 |
CTD |
| G |
Klc1 |
kinesin light chain 1 |
|
affects expression |
ISO |
6 |
136,553,146 |
136,586,393 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
affects expression |
ISO |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Ksr1 |
kinase suppressor of ras 1 |
|
affects expression |
ISO |
10 |
65,186,444 |
65,322,155 |
RGD:6480464 |
CTD |
| G |
Lims1 |
LIM and senescent cell antigen-like domains 1 |
|
affects expression |
ISO |
20 |
37,349,188 |
37,397,427 |
RGD:6480464 |
CTD |
| G |
Lmnb1 |
lamin B1 |
|
affects expression |
ISO |
18 |
52,470,605 |
52,508,022 |
RGD:6480464 |
CTD |
| G |
Maf |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) |
|
affects expression |
ISO |
19 |
45,859,510 |
45,861,454 |
RGD:6480464 |
CTD |
| G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
|
affects expression |
ISO |
10 |
95,482,303 |
95,551,065 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
EXP |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
affects expression |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases expression |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
|
affects expression |
ISO |
3 |
76,781,504 |
76,790,661 |
RGD:6480464 |
CTD |
| G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
|
affects expression |
ISO |
10 |
14,147,895 |
14,186,277 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
increases expression |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
|
affects expression |
ISO |
5 |
136,100,236 |
136,141,344 |
RGD:6480464 |
CTD |
| G |
Mlst8 |
MTOR associated protein, LST8 homolog (S. cerevisiae) |
|
affects expression |
ISO |
10 |
13,725,510 |
13,731,261 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
affects expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mos |
Moloney sarcoma oncogene |
|
affects expression |
ISO |
5 |
17,158,906 |
17,160,204 |
RGD:6480464 |
CTD |
| G |
Ncl |
nucleolin |
|
affects expression |
ISO |
9 |
85,112,752 |
85,121,276 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
|
affects expression |
ISO |
8 |
77,252,500 |
77,337,402 |
RGD:6480464 |
CTD |
| G |
Nfia |
nuclear factor I/A |
|
affects expression |
ISO |
5 |
118,152,938 |
118,507,056 |
RGD:6480464 |
CTD |
| G |
Nfic |
nuclear factor I/C |
|
affects expression |
ISO |
7 |
9,768,135 |
9,793,584 |
RGD:6480464 |
CTD |
| G |
Pabpc1 |
poly(A) binding protein, cytoplasmic 1 |
|
affects expression |
ISO |
7 |
72,116,140 |
72,128,433 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
affects expression |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pik3c2a |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha |
|
affects expression |
ISO |
1 |
174,430,831 |
174,537,706 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
affects expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
affects expression |
ISO |
7 |
117,266,784 |
117,307,172 |
RGD:6480464 |
CTD |
| G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
|
affects expression |
ISO |
20 |
2,940,605 |
2,984,636 |
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
affects expression |
ISO |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
|
affects expression |
ISO |
8 |
106,061,334 |
106,155,090 |
RGD:6480464 |
CTD |
| G |
Ppp2r5a |
protein phosphatase 2, regulatory subunit B', alpha |
|
affects expression |
ISO |
13 |
107,413,761 |
107,458,156 |
RGD:6480464 |
CTD |
| G |
Ppp2r5c |
protein phosphatase 2, regulatory subunit B', gamma |
|
affects expression |
ISO |
6 |
135,204,405 |
135,299,068 |
RGD:6480464 |
CTD |
| G |
Ppp3r1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
affects expression |
ISO |
14 |
98,060,302 |
98,099,092 |
RGD:6480464 |
CTD |
| G |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
|
affects expression |
ISO |
12 |
41,840,866 |
41,851,241 |
RGD:6480464 |
CTD |
| G |
Prkab2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
|
affects expression |
ISO |
2 |
192,498,430 |
192,510,624 |
RGD:6480464 |
CTD |
| G |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
|
affects expression |
ISO |
2 |
244,949,303 |
245,035,266 |
RGD:6480464 |
CTD |
| G |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I, beta |
|
affects expression |
ISO |
12 |
16,025,867 |
16,131,129 |
RGD:6480464 |
CTD |
| G |
Prkar2a |
protein kinase, cAMP dependent regulatory, type II alpha |
|
affects expression |
ISO |
8 |
113,746,384 |
113,805,476 |
RGD:6480464 |
CTD |
| G |
Prkci |
protein kinase C, iota |
|
affects expression |
ISO |
2 |
116,739,625 |
116,801,084 |
RGD:6480464 |
CTD |
| G |
Ptpn5 |
protein tyrosine phosphatase, non-receptor type 5 |
|
affects expression |
ISO |
1 |
97,629,192 |
97,643,225 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
affects expression |
ISO |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Pxn |
paxillin |
|
affects expression |
ISO |
12 |
42,322,193 |
42,370,507 |
RGD:6480464 |
CTD |
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
affects expression |
ISO |
8 |
77,798,830 |
77,861,090 |
RGD:6480464 |
CTD |
| G |
Rarg |
retinoic acid receptor, gamma |
|
increases expression |
ISO |
7 |
140,991,447 |
141,014,108 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
affects expression |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
affects expression |
ISO |
3 |
32,101,433 |
32,118,785 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
affects expression |
ISO |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rps6ka3 |
ribosomal protein S6 kinase polypeptide 3 |
|
affects expression |
ISO |
X |
56,722,878 |
56,825,444 |
RGD:6480464 |
CTD |
| G |
Safb2 |
scaffold attachment factor B2 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
affects expression |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Shc1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
|
affects expression |
ISO |
2 |
181,616,581 |
181,628,144 |
RGD:6480464 |
CTD |
| G |
Sirpa |
signal-regulatory protein alpha |
|
affects expression |
ISO |
3 |
117,210,116 |
117,247,840 |
RGD:6480464 |
CTD |
| G |
Slmap |
sarcolemma associated protein |
|
affects expression |
ISO |
16 |
1,707,264 |
1,822,281 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
affects expression |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smc1a |
structural maintenance of chromosomes 1A |
|
affects expression |
ISO |
X |
41,503,393 |
41,547,830 |
RGD:6480464 |
CTD |
| G |
Sox4 |
SRY (sex determining region Y)-box 4 |
|
increases expression |
ISO |
17 |
42,172,863 |
42,177,590 |
RGD:6480464 |
CTD |
| G |
Sptbn1 |
spectrin, beta, non-erythrocytic 1 |
|
affects expression |
ISO |
14 |
111,076,741 |
111,246,286 |
RGD:6480464 |
CTD |
| G |
Stat5b |
signal transducer and activator of transcription 5B |
|
affects expression |
ISO |
10 |
89,716,624 |
89,743,134 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
affects expression |
ISO |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Tgfbr3 |
transforming growth factor, beta receptor III |
|
affects expression |
ISO |
14 |
3,051,039 |
3,240,286 |
RGD:6480464 |
CTD |
| G |
Tgs1 |
trimethylguanosine synthase 1 |
|
affects expression |
ISO |
5 |
16,818,391 |
16,851,916 |
RGD:6480464 |
CTD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
affects expression |
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
affects expression |
ISO |
2 |
155,312,341 |
155,339,357 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
affects expression |
ISO |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
affects expression |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tp63 |
tumor protein p63 |
|
affects expression |
ISO |
11 |
76,900,622 |
77,200,251 |
RGD:6480464 |
CTD |
| G |
Tspan5 |
tetraspanin 5 |
|
affects expression |
ISO |
2 |
236,314,737 |
236,487,072 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
affects expression |
ISO |
11 |
34,617,072 |
34,659,043 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
affects expression |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
affects expression |
ISO |
5 |
77,263,334 |
77,295,794 |
RGD:6480464 |
CTD |
| G |
Vcl |
vinculin |
|
affects expression |
ISO |
15 |
3,478,214 |
3,576,911 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
affects expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Ywhab |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
|
affects expression |
ISO |
3 |
154,926,025 |
154,948,297 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
affects expression |
ISO |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Zfpm1 |
zinc finger protein, multitype 1 |
|
affects expression |
ISO |
19 |
52,526,720 |
52,587,089 |
RGD:6480464 |
CTD |
Term paths to the root
|